Companies

MUSTANG BIO, INC.

MBIO · CIK 0001680048 · operating

$0.97-4.00%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$6.99M
P/E
Fwd P/E-2.74
PEG
P/S
P/B0.72
EV/EBITDA7.27
EV/Rev

Profitability

Gross Margin
Op. Margin
Net Margin
ROE406.71%
ROA-169.23%
FCF Margin

Financial Health

Current Ratio0.68
Debt/Equity-3.40
Free Cash Flow-$11.41M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth-542.83%
Beta2.16
52W High$7
52W Low$0.531

About MUSTANG BIO, INC.

MUSTANG BIO, INC. (MBIO) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $8 million, MUSTANG BIO, INC. is a micro-cap company. The stock currently trades at $0.97, down 4.00% today, with a 52-week range of $0.53–$7.00.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-38.57$-38.57-542.8%
2023$-6.00$-6.00-700.0%
2022$-0.75$-0.75
2021
2020
2019
2018
2017
2016

Annual Reports (10-K) · 9 filings

Report DateFiledAccession Number
2024-12-312025-03-280001558370-25-003913SEC ↗
2023-12-312024-03-110001558370-24-002899SEC ↗
2022-12-312023-03-300001558370-23-004979SEC ↗
2021-12-312022-03-230001558370-22-004143SEC ↗
2020-12-312021-03-240001558370-21-003433SEC ↗
2019-12-312020-03-160001104659-20-034130SEC ↗
2018-12-312019-03-180001144204-19-014624SEC ↗
2017-12-312018-03-290001144204-18-017988SEC ↗
2016-12-312017-03-310001144204-17-017831SEC ↗